semaglutide compounding enforcement news FDA free to pursue compounders after latest court ruling Compound versions of GLP-1 drugs

Tirzepatide was compared to once-weekly oral semaglutide in the SURPASS-2 study, an open-label, phase 3 clinical trial with a 40-week follow-up that enrolled T2DM patients with a BMI of 25 kg/m 2 and an HbA1c of 710.5% despite taking at least a 1500 mg dose of metformin

IGF-1 LR3 1mg $99.99 IGF-1 LR3 1mg is a high-purity research peptide supplied in a precisely measured vial to support consistency and accuracy in laboratory applications

Vitamin B12 supports the nervous system by maintaining myelin, which is the protective coating around nerves

A study published in Diabetes, Obesity and Metabolism in January 2025 followed 262 patients treated with GLP-1 agonists in Ireland

Albiglutide Albiglutide achieves extended systemic activity through genetic fusion with human serum albumin (HSA), a strategy distinct from the fatty acid-based albumin binding used in agents like liraglutide and semaglutide

LB54640 is a small molecule MC4R agonist licenced from LG Chem Ltd